CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-29 | FMR LLC | Conversion | +304,576 | 1,118,054 | ||
| 2018-01-29 | FMR LLC | Conversion · Series B Preferred Stock | −2,194,357 | 0 | ||
| 2018-01-29 | FMR LLC | Conversion · Series C Preferred Stock | −821,596 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +2,584 | 1,418,005 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +66 | 36,358 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +849,794 | 2,267,799 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +21,789 | 58,147 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +127,269 | 2,395,068 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion | +3,263 | 61,410 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series A Preferred Stock | −6,971 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series A Preferred Stock | −179 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series B Preferred Stock | −2,292,320 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series B Preferred Stock | −58,777 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series C Preferred Stock | −343,310 | 0 | ||
| 2018-01-29 | Presidio Partners 2007 GP, L.P. 10% owner | Conversion · Series C Preferred Stock | −21,789 | 0 | ||
| 2018-01-29 | venBio Global Strategic Fund II L.P. 10% owner | Conversion | +1,196,552 | 1,461,552 | ||
| 2018-01-29 | venBio Global Strategic Fund II L.P. 10% owner | Conversion · Series C Preferred Stock | −3,227,700 | 0 | ||
| 2018-01-29 | Remeditex Ventures LLC 10% owner | Conversion | +2,650 | 1,585,504 | ||
| 2018-01-29 | Remeditex Ventures LLC 10% owner | Conversion | +871,583 | 2,457,087 | ||
| 2018-01-29 | Remeditex Ventures LLC 10% owner | Conversion | +304,576 | 2,761,663 |
Page 20 of 22 · 425 trades